Evidence map›Paper›PMID 31578744›Full record

ReviewAnnals of the New York Academy of Sciences2020

Opioid-sparing effects of 10 kHz spinal cord stimulation: a review of clinical evidence.

Adnan Al-Kaisy, Jean-Pierre Van Buyten, Kasra Amirdelfan, Bradford Gliner, David Caraway, Jeyakumar Subbaroyan, Anand Rotte, Leonardo Kapural

Open access · hybridAbstract readReview
In one paragraph

Review in Annals of the New York Academy of Sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
13.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 62 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Pain, quality of life, and function in chronic intractable leg pain were substantially improved with 10kHz spinal cord stimulation in a multicentre European study.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2025
    Observational
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 4 countries.

Adnan Al-KaisyThe Pain Management and Neuromodulation Centre, Guy's and St. Thomas' Hospital, London, United Kingdom.
Jean-Pierre Van BuytenMultidisciplinary Pain Centre, AZ Nikolaas, St Niklaas, Belgium.
Kasra AmirdelfanIPM Medical Group, Inc., Walnut Creek, California.
Bradford GlinerNevro Corp., Redwood City, California.
David CarawayNevro Corp., Redwood City, California.
Jeyakumar SubbaroyanNevro Corp., Redwood City, California.
Anand RotteNevro Corp., Redwood City, California.
Leonardo KapuralCarolina's Pain Institute, Winston-Salem, North Carolina.
Nevro (United States) · USKaiser Permanente Walnut Creek Medical Center · USSt. Thomas Hospital · CAUniversity of North Carolina at Chapel Hill · USVlaamse Vereniging voor Obstetrie en Gynaecolo · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic pain is a common condition that affects the physical, emotional, and mental well-being of patients and can significantly diminish their quality of life. Due to growing concerns about the substantial risks of long-term opioid use, both governmental agencies and professional societies have recommended prioritizing the use of nonpharmacologic treatments, when suitable, in order to reduce or eliminate the need for opioid use. The use of 10 kHz spinal cord stimulation (10 kHz SCS) is one such nonpharmacologic alternative for the treatment of chronic, intractable pain of the trunk and limbs. This review examines published clinical data regarding the efficacy of 10 kHz SCS for decreasing chronic pain in patients and its potential to reduce or eliminate opioid usage. Multiple prospective and retrospective studies in patients with intractable pain demonstrated that 10 kHz SCS treatment provided ≥50% pain relief in >70% patients after at least 1 year of treatment. Pain relief with 10 kHz SCS therapy ranged from 54% to 87% in the studies. More importantly, the mean daily dose of opioids required by patients in these studies was reduced after 10 kHz SCS treatment, and on average over 60% patients in studies either reduced or eliminated opioids at the last follow-up.

Indexed as

Analgesics, OpioidChronic PainHumansOpioid-Related DisordersPain ManagementRandomized Controlled Trials as TopicSpinal Cord StimulationAnalgesics, Opioid10 kHz SCSchronic painopioids

Identifiers

PMID31578744
PMCPMC7065058
OpenAlexW2977482812

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.